Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

CvLPRIT: Complete revascularization benefits persist long term

Key clinical point: The cardiovascular benefits of complete revascularization after ST-segment elevation myocardial infarction persist to at least 5 years.

Major finding: Complete revascularization was associated with a significant 43% lower rate of major adverse cardiovascular events than target-artery revascularization at 5.6 years of follow-up.

Study details: Long-term follow-up of 272 patients with STEMI in the CvLPRIT study.

Disclosures: The CvLPRIT study was funded by the British Heart Foundation, with support from the National Institute for Health Research Comprehensive Local Research Networks. No conflicts of interest were declared.


Gershlick A et al. J Am Coll Cardiol. 2019 Dec 16;74:3083-9.